SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-033910
Filing Date
2020-10-29
Accepted
2020-10-29 14:28:39
Documents
20
Period of Report
2020-10-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea129108-8k_emmanuslife.htm 8-K 20919
2 COMPANY PRESENTATION AT SEPTEMBER 17, 2020 VIRTUAL STOCKHOLDERS MEETING ea129108ex99-1_emmanuslife.htm EX-99.1 23256
3 GRAPHIC ex99-1_001.jpg GRAPHIC 238621
4 GRAPHIC ex99-1_002.jpg GRAPHIC 393852
5 GRAPHIC ex99-1_003.jpg GRAPHIC 324265
6 GRAPHIC ex99-1_004.jpg GRAPHIC 437611
7 GRAPHIC ex99-1_005.jpg GRAPHIC 331318
8 GRAPHIC ex99-1_006.jpg GRAPHIC 264913
9 GRAPHIC ex99-1_007.jpg GRAPHIC 257215
10 GRAPHIC ex99-1_008.jpg GRAPHIC 310384
11 GRAPHIC ex99-1_009.jpg GRAPHIC 238501
12 GRAPHIC ex99-1_010.jpg GRAPHIC 316450
13 GRAPHIC ex99-1_011.jpg GRAPHIC 347978
14 GRAPHIC ex99-1_012.jpg GRAPHIC 253618
15 GRAPHIC ex99-1_013.jpg GRAPHIC 301658
16 GRAPHIC ex99-1_014.jpg GRAPHIC 262149
17 GRAPHIC ex99-1_015.jpg GRAPHIC 297150
18 GRAPHIC ex99-1_016.jpg GRAPHIC 192115
19 GRAPHIC ex99-1_017.jpg GRAPHIC 53780
20 GRAPHIC ex99-1_018.jpg GRAPHIC 392401
  Complete submission text file 0001213900-20-033910.txt   6843641
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 201271976
SIC: 2834 Pharmaceutical Preparations